The VMMC training has the 10 modules as follows:

1. Introduction to Voluntary Medical Male Circumcision
2. Before the Procedure: Facilities and supplies
3. Medical Procedure for Adults and Adolescents
4. Post Procedure Care
5. Management of Adverse Events
6. Infection Prevention and Control.
7. Continuous Quality Insurance
8. Counselling
9. Demand Generation
10. Data Management and Recording

Course objectives:

• Empower participants with the knowledge needed to establish or improve infection prevention practices at their health facilities. 
• To ensure the provision of high quality, standardised VMMC training.
• Capacity building in collaboration with the Regional Training Centres (RTC).
• To provide mentoring and support in addition to skills acquisition, to ensure competency.

The ACC curriculum consists of 25 sub-modules. The overall goal of this training is enhanced clinical competency to manage complex patients with HIV and HIV/TB in all population groups (adults, children, adolescents, and pregnant women). The training curriculum will provide healthcare professionals with an approach towards the assessment, investigation, and management of patients with advanced HIV disease and common infections, complications, and comorbidities in each organ system.

Module 1 – Core topics

• Module 1.1. Epidemiology
• Module 1.2. Principles of antiretroviral therapy

Module 2 – Management of the HIV-positive person with advanced disease

• Module 2.1. General approach to the hospitalized HIV-positive person
• Module 2.2. Management of the HIV-positive person with respiratory symptoms
• Module 2.3. Management of the HIV-positive person with a positive serum cryptococcal antigen
• Module 2.4. Management of the HIV-positive person with headache and other neurological symptoms
• Module 2.5. Management of the HIV-positive person with generalized systemic symptoms
• Module 2.6. Management of the HIV-positive person with liver disease
• Module 2.7. Management of the HIV-positive person with kidney disease
• Module 2.8: Management of the HIV-positive person with cytopenia
• Module 2.9. Management of the HIV-positive person with clinical deterioration after initiating HAART

Module 3 – Management of treatment failure and HIV drug resistance

• Module 3.1. Epidemiology of HIV drug resistance
• Module 3.2. Principles of HIV drug resistance testing and interpretation
• Module 3.3. Management of patients with high viral load
• Module 3.4. Management of adult patients failing an NNRTI based regimen
• Module 3.5. Management of adult patients failing a dolutegravir based regimen
• Module 3.6. Management of patient failing a protease inhibitor-based regimen
• Module 3.7. Management of a patient with a high viral load with clinical co-morbidities
• Module 3.8. Management of low-level viraemia
• Module 3.9. Management of treatment failure in the pregnant woman
• Module 3.10. Management of treatment failure in infants, children and adolescents

Module 4 – Special challenges with antiretroviral therapy

• Module 4.1. Adverse drug reactions
• Module 4.2. Drug-drug interactions
• Module 4.3. Management of HIV and hepatitis B virus coinfection in the context of chronic kidney disease
• Module 4.4. Neonatal challenges

The course has 4 modules as follows: 

Module 1: Introduction and general overview

• Why is patient harm a global priority?
• Why develop a national PSI reporting and learning systems
• Revision of the guideline
• Purpose and objectives
• Legal and policy framework
• Scope
• Mandatory requirements
• Definitions
• What is reported?
• Steps to manage PSIs
• Progress made since implementation

Module 2 - Part 1: Management of PSI: Step 1 to 5

• Step 1: Identifying PSIs
• Step 2: Immediate action taken
• Step 3: Prioritisations
• Step 4: Notification
• Step 5: Investigation (including RCA)

Module 2 - Part 2: Management of PSI: Step 6 to 9

• Step 6: Classification
• Step 7: Analysis
• Step 8: Implementation of recommendations
• Step 9: Learning

Module 3 - Part 1: PSI classifications, examples, and explanations: PSI Type

• Practical examples and explanations provided for the sub-classification for incident types

Module 3 - Part 2: PSI classifications, examples, and explanations: Contributing factors and outcomes

• Practical examples and explanations provided for the sub-classification for contributing factors and the main classifications for patient and organisational outcome

Module 4: Implementation, reporting and learning

• Implementation through Patient Safety Committees
• How can we create an environment that encourages PSI reporting?
• How to minimize errors?
• Monitoring and compliance
• Web-based information system
• How to obtain access
• PSI capture form
• Reports
• Dashboards

The course has two modules as follows:

Module 1: Introduction, general overview and management 

• Background
• Purpose 
• Legal and policy framework
• Scope
• Definitions
• Committees
• Complaints management 
• Compliment and suggestion management 
   

Module 2: Implementation, reporting and learning

• Implementation through Complaints, Compliments and Suggestions (CCS) Committees
• Monitoring and compliance
• Web-based information system

This is a self-facilitated online course. You complete it at your own pace and in your own time. It should take you about three to six hours in total to complete and will be open for six weeks from registration to give sufficient opportunity to complete the course. There are no prerequisites for the course.

It is divided into nine unit and assessment quizzes:

• Introduction
• Unit 1: What is antimicrobial resistance and why should we care?
• Unit 2: How can we deal with antimicrobial resistance? Infection prevention and control
• Unit 3: How can we deal with antimicrobial resistance?
• Unit 4: How can we prevent infections?
• Unit 5: How can we use antimicrobials better?
• Unit 6: What is empiric and directed therapy?
• Unit 7: What AMR advocacy is happening?
• Unit 8: How can we implement AMR prevention strategies?
• Unit 9: How can we supply and dispose of antimicrobials?

Course objectives

This online training programme is designed to ensure that all HCWs have appropriate baseline antimicrobial and infection prevention and control (IPC) competency, to complement existing knowledge and skills by:

• Increasing the level of understanding of AMR and IPC in all HCWs to engender best practices in their daily setting, regularly and consistently.
• Ensuring the appropriate use of antimicrobials to reduce resistance, adverse events, and improve patient outcomes.
• Ensuring understanding of the use and implementation of appropriate IPC measures to prevent transmission of microbes (including multi-drug resistant microbes) and reduce infections.
• Ensuring appropriate use of laboratory services to optimize the use of antimicrobials. 
• Ensuring that HCWs understand and appreciate the multidisciplinary nature of antimicrobial stewardship, and the roles of each member in the stewardship team.

The target audience for this course are all HCWs registered with the following councils: Health Professions Council of South Africa (HPCSA); South African Nursing Council (SANC); South African Veterinary Council (SAVC); South African Pharmacy Council (SAPC).

The updates includes seven units as follows:

1. Dolutegravir
2. First-line ART regimens
3. Dual treatment of HIV and TB
4. Monitoring on ART, switching regimens, and managing an elevated viral load (VL)
5. Second line ART
6. TB preventative therapy (TPT)
7. Switching regimens for second-line clients

Updates objectives:

• Share the latest information on the management of clients on TLD.
• Guide clinicians on the switching of stable second-line clients to the DTG-containing regimen.
• Share the latest information on viral-load monitoring and management.
• Highlight critical areas for the provision of integrated ART, TB and family planning services.

• Module 1: Introduction to COVID-19 vaccination training
• Module 2: Storage, handling, delivery, and waste management of COVID-19 vaccines
• Module 3: Organising COVID-19 vaccination sessions
• Module 4: Adverse events following immunisation (AEFI) monitoring for COVID-19 vaccination
• Module 5: COVID-19 vaccination data management
• Module 6: Communication with the community about COVID-19 vaccination
• Module 7: Ethical considerations for the COVID-19 vaccination programme

Learning objectives

The overall aim of this course is to capacitate vaccinators by providing key information necessary for rolling out the COVID-19 vaccine to South African healthcare workers. At the end of this course participants will be able to:

• get an overview of the COVID-19 vaccination training curriculum and processes
• briefly describe SARS-CoV-2 and coronavirus disease (COVID-19)
• provide key information on types of COVID-19 vaccines
• outline the NDoH vaccination strategy for healthcare workers
• identify key programmatic considerations that are new or different for COVID-19 vaccines
• describe key planning elements to prepare for the COVID-19 vaccine introduction
• explain cold-chain requirements for the COVID-19 vaccines and diluents
• explain storage principles / conditions at the health facility as well as for outreach and campaign vaccination posts
• understand the ethical principles and values relevant to the vaccine programme
• explain the ethical justification for the prioritisation in the roll out programme
• as health care workers, understand their ethical duties towards individuals they will be vaccinating 
• describe health and human rights, and how these notions can be applied to the vaccine programme.

WHAT IS HIV?
1.1. The Human Immunodeficiency Virus and its life cycle
1.1. Knowledge check
1.2. HIV transmission
1.2. Knowledge check
1.3. Stages of infection
 

PREVENTION OF HIV AND AIDS
2.1. Prevention measures
2.1. Knowledge check
2.2. Managing exposure to HIV
 

DIAGNOSIS
3.1. HIV Testing Services
3.2. HIV testing
3.2. Knowledge check
3.3. HIV clinical staging
 

ANTIRETROVIRAL THERAPY
4.1. What is antiretroviral therapy?
4.1. Knowledge check
4.2. Initiating ART
4.2. Knowledge check
4.3. VL monitoring, switching to TLD, and managing an elevated VL
4.4. Second-line ART
4.4. Knowledge check
4.5. Stigma and discrimination
4.6. ARV resistance
 

HIV AND OTHER DISEASES
5.1. Preventing and managing common opportunistic infections
5.1. Knowledge check
5.2. Managing common sexually transmitted infections
5.2. Knowledge check
5.3. HIV and airborne infections
5.3. Knowledge check
5.4. TB screening and TB preventive therapy
5.5. Managing TB in adults
5.5. Knowledge check
5.6. Managing TB in children
5.6. Knowledge check
5.7. HIV and non-communicable comorbidities
 

MOTHERS AND CHILDREN
6.1. Contraceptives and HIV
6.1. Knowledge check
6.2. Prevention of Mother to Child Transmission (PMTCT)
6.2. Knowledge check
6.3. Paediatric HIV
 

NUTRITION
7.1. Nutrition in the context of HIV